Dupixent, Flu Vaccine Demand Boosts Sanofi’s Q3 Results, Raises Annual…

Sanofi SA SNY said it now expects adjusted earnings per share to grow about 16% in 2022. The positive currency impact on the company’s EPS in 2022 is estimated at +9.5% to +10.5%. had it before projected growth of 15%. The company announced this Q3 Revenue of €12.48bn, +19.7% Y/Y, supported by strong specialty […]